speaker

Bor-Sheng (Kevin) Ko

Bor-Sheng (Kevin) Ko received his M.D. degree in Medical College of National Taiwan University, and Ph.D. degree from the Institute of Clinical Medicine, National Taiwan University in 2011. He is currently an attending physician of the Hematology Division and assistant professor at National Taiwan University Hospital (NTUH), the president of Taiwan Society of Blood and Marrow Transplant (TBMT), and the president of Taiwan Society of Pharmacoeconomics and Outcome Research (TASPOR). In addition, he also serves as a committee member of multiple committees in Taiwan Food and Drug Administration (TFDA), and Ministry of Science and Technology (MOST) in the past years. He is the co-founder for this NTUH IRB approved AHEAD project and responsible for clinical validation for the algorithm and development for related clinical application.